Stock
Pharma stocks soar after US midterm elections
November 8, 2018Business Services, Manufacturing and Production Shares, Stock, Trump, biotech, pharma, stock market
Despite the threat of a bipartisan pricing plan, pharma stocks have soared after the announcement of the results of the …
Galena’s breast cancer immunotherapy fails in late-stage trials; shares plunge
June 30, 2016Research and Development, Sales and Marketing Galena Biopharma, Stock, breast cancer, drug trial
Shares in Galena Biopharma (Nasdaq: GALE) dropped over 80% after the company said an independent Data Monitoring Committee recommended that …
Weekly Movers: Relypsa, Titan Pharma, Allergan…
June 6, 2016Research and Development, Sales and Marketing Stock, drug trial, research, stock market
The prestigious ASCO meet is underway and results of new drug trials will be a key stock mover over the …
Weekly Movers: XenoPort, Akari, Bayer…
May 31, 2016Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Sarepta Therapeutics, Stick Market, Stock, Xenoport, finance
Bayer-Monsanto story comes close on the heels of Sanofi-Medivation tussle as the pharma sector goes through the motions of consolidation. …
Aduro’s pancreatic cancer immunotherapy fails Phase II trials; shares plunge
May 17, 2016Manufacturing and Production, Research and Development, Sales and Marketing Aduro Biotech, Pancreatic cancer, Stock, drug trial, markets
Shares in Aduro Biotech (Nasdaq: ADRO) dropped to closed down over 16% after the company said mid-stage trials of its …
Weekly Movers: Teva, Midatech, Allergan…
May 16, 2016Research and Development, Sales and Marketing Allergan, Ariad Pharmaceuticals, Lundbeck, Midatech Pharma, Stock, Teva Pharmaceutical, markets
We have hit the tail end of the earnings season and the near last batch of movers follow result pronouncements …
Pfizer enters $5 billion share buyback deal with Goldman Sachs
March 9, 2016Business Services, Research and Development Pfizer, Share buyback, Stock, markets
US drug major Pfizer (NYSE: PFE) on Wednesday said it has entered into an accelerated share repurchase agreement with Goldman, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
